WO2006117977A1 - Process for production of carbostyril compound - Google Patents
Process for production of carbostyril compound Download PDFInfo
- Publication number
- WO2006117977A1 WO2006117977A1 PCT/JP2006/307461 JP2006307461W WO2006117977A1 WO 2006117977 A1 WO2006117977 A1 WO 2006117977A1 JP 2006307461 W JP2006307461 W JP 2006307461W WO 2006117977 A1 WO2006117977 A1 WO 2006117977A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- formula
- salt
- reaction
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
Definitions
- the present invention relates to an improved method for producing a carbostyril compound, which produces the following carbostyril compound which is useful as a therapeutic agent for gastric ulcer and the like more safely and efficiently.
- the carboschirirui compound of the present invention is a carboschirirui compound represented by the following formula (1) (chemical name: 2— (4 black benzoylamino)-3- [2 (1 ⁇ ) -quinolinone 4-yl] propionic acid), a drug that exhibits excellent therapeutic effects on gastric mucosal lesions appearing during gastric ulcer, acute gastritis, or acute exacerbation of chronic gastritis.
- formula (1) chemical name: 2— (4 black benzoylamino)-3- [2 (1 ⁇ ) -quinolinone 4-yl] propionic acid
- Patent Document 1 a method represented by the following reaction formula 1 is known (Patent Document 1). That is, the compound of formula (2) is reacted with the compound of formula (3) in the presence of a base such as sodium ethoxide to obtain the compound of formula (4), and this compound is hydrolyzed with a mineral acid such as hydrochloric acid. And decarboxylating to produce the compound of formula (5), and then saponifying with 4-chlorobenzoyl chloride of formula (6) to produce the desired compound of formula (1).
- a base such as sodium ethoxide
- a mineral acid such as hydrochloric acid
- the step of producing the compound of the formula (5) from the compound of the formula (4) is required to heat and reflux the compound (4) in, for example, 20% hydrochloric acid.
- the reaction interface is bubbling violently due to the generated carbon dioxide gas, and this foam does not disappear immediately.
- the amount of hydrochloric acid relative to compound (4) is small, a rapid increase in the interface due to the bubbles is observed, and it is often difficult to carry out the refluxing continuously.
- Patent Document 1 Japanese Patent Application Laid-Open No. 60-19767
- An object of the present invention is to provide an improved method by which a carbostyril compound of formula (1) or a salt thereof useful as a medicament can be produced more safely and efficiently.
- the compound of formula (5) or a salt thereof produced as an intermediate in the production method of the present invention is an intermediate substance for producing a desired carbostyril compound or a salt thereof of formula (1). It is desired that the crystal can be easily and easily removed from the reaction system. Moreover, in order to be suitable for storage as an intermediate substance for producing a desired carboschiril compound of the formula (1) or a salt thereof, it is desired that the drying can be performed more easily and efficiently. .
- Another object of the present invention is to provide a compound of the formula (4) during a series of steps for producing the desired carbostyril compound of the formula (1) or a salt thereof from the compound of the formula (2) or a salt thereof.
- heating in the presence of a high-boiling point solvent suitable for this step causes a sudden reaction caused by bubbles generated during the reaction.
- the present invention provides a method for more safely producing the desired carbostyryl compound (formula (1)) or a salt thereof by suppressing the rise of the interface and bumping accompanying this.
- Another object of the present invention is to improve the above-mentioned problem of preventing bumping, while maintaining the reflux temperature while removing by-products such as ethanol and ethyl acetate in the reaction step as necessary.
- the present invention also provides a method for producing the compound 5) or a salt thereof more efficiently.
- a further object of the present invention is to provide a dihydrochloride dihydrate of the compound of formula (5) as the desired intermediate.
- the compound of formula (5) or a salt thereof can be produced safely by heating the compound of formula (4) or a salt thereof in the presence of a high-boiling solvent under acidic conditions.
- the production of the compound of formula (5) or a salt thereof can be carried out more efficiently by maintaining the heating temperature, particularly the reflux temperature, while removing by-products such as ethanol and ethyl acetate in the reaction step as necessary. Can do.
- the compound (5) or a salt thereof is acylated with 4 chlorobenzoyl chloride of the formula (6) to obtain the target carbostyryl compound of the formula (1) or a salt thereof.
- the reaction when the compound of the formula (4) or a salt thereof is heated under acidic conditions to derive the compound of the formula (5) or a salt thereof, the reaction is performed with a specific high boiling point solvent.
- the high boiling point solvent functions as an antifoaming agent, suppresses undesirable foaming, and adds sufficient caloric heat to accelerate the reaction.
- the step of heating the compound of the formula (4) or a salt thereof to obtain the compound of the formula (5) or a salt thereof is performed in water, and Z or of the formula (5) Reaction process power to obtain a target carbostyril compound of the formula (1) or a salt thereof by subjecting the compound or a salt thereof to acylation
- the above formula (5) carried out in water, an organic solvent or a mixture thereof Or a salt thereof, or a method for producing a carbostyril compound of the formula (1) or a salt thereof.
- a reaction in which the heating reaction is carried out in the presence of hydrochloric acid ( 5) A method for producing a compound or a salt thereof can be provided.
- the high boiling point solvent used in the step of heating the compound of the formula (4) or a salt thereof to obtain the compound of the formula (5) or a salt thereof is normal octanol and Z
- the compound of the formula (5) or a salt thereof obtained by the production method of the present invention is a dihydrochloride dihydrate of the compound represented by the formula (5). It is possible to provide new substances with features.
- the high boiling point solvent used in the present invention may be any substance that can perform the above-described operation without any trouble.
- the solvent is a substance that can suppress the rise of the interface due to foaming caused by the generation of the carbon dioxide gas, and It must azeotrope with the solvent added with the acid used in the reaction, have a higher specific gravity than the solvent added with the acid, and be separated without mixing with the solvent added with the acid, and have a higher boiling point than the solvent added with the acid. Has been found to be suitable for that purpose.
- the inventors of the present invention can preferably illustrate hydrochloric acid as the acid used in the production method of the present invention, as shown in the examples below, and the corresponding high-boiling solvent has a specific gravity higher than that of hydrochloric acid, for example. It has been found that normal otatanol and Z or acetophenone, which are high-boiling substances that are not mixed with small hydrochloric acid, are more suitable for that purpose.
- the reaction leading to the compound of formula (4) or a salt thereof by acid hydrolysis to the compound of formula (5) or a salt thereof is carried out by using a high-boiling solvent in the presence of a hydrolysis catalyst. It is done by adding.
- Hydrolysis catalysts include halogen hydrofluoric acids such as hydrochloric acid, hydrobromic acid and hydroiodic acid, mineral acids such as sulfuric acid and phosphoric acid, and organic acids such as formic acid, acetic acid, trifluoroacetic acid and p-toluenesulfonic acid.
- hydrochloric acid can be exemplified.
- catalysts can be used singly or in combination of two or more.
- water contained in hydrochloric acid which may be used as the reaction solvent with a solvent such as water in which the acid is dissolved, is particularly preferred as the solvent for the reaction.
- the amount of acid used as the catalyst is not particularly limited.
- hydrochloric acid is used as the acid.
- it can also be used as a solvent for the reaction, and the concentration is usually
- the high boiling point solvent that can be used in the present invention results from the generation of carbon dioxide gas by-produced in the step of heating and reacting the compound of the above formula (4) or a salt thereof under acidic conditions. It exists as a substance (including defoaming effect) that can suppress the rise of the interface due to foaming (including defoaming), does not mix with the solvent to which the acid is added, and is used for the reaction. There is no particular limitation as long as it is a substance that has physico-chemical properties that azeotropes with the solvent to which the acid is added and has a higher boiling point and lower specific gravity than the solvent to which the acid is added. .
- high boiling point solvent examples include normal pentanol, 2-pentanol, 3-pentanol, 3-methyl-1-butanol, normal hexanol, 2-methyl-1-pentanol, 2-ethyl-1-butanol, and 3 Ptanol, normal otathanol, normal nonanol, 3, 5, 5 trimethyl- 1 hexanol, normalde force norm, normalunde force norl, normal dodecanol etc.
- hydrochloric acid is used also as an acid catalyst and a solvent for the reaction
- normaloctanol and acetophenone having physical and physical properties satisfying the above conditions are more suitable. It can be used as a high boiling point solvent.
- the amount of the high-boiling solvent used is not particularly limited, and the preferred amount varies depending on the degree of foaming, the shape of the reaction vessel, etc., but with respect to 1 part by weight of the compound of formula (4) or a salt thereof, Usually, a range force of about 0.1 to 3 parts by volume, preferably about 0.1 to 1 parts by volume is also selected.
- the above reaction is usually carried out by heating from 80 ° C. to the reflux temperature of the reaction solvent, preferably 100 ° C. and the reaction solvent, and is usually completed in about 6 to 24 hours.
- the high-boiling solvent used in the production method of the present invention has the effect of suppressing an increase in the reaction liquid interface in the step of heating and reacting the compound of formula (4) or a salt thereof under acidic conditions. Since the compound of formula (5) or a salt thereof can be produced safely and the volumetric efficiency of the reactor can be greatly increased, it can be used for mass synthesis of the compound of formula (5) or a salt thereof. It can be suitably used.
- the compound of the formula (5) In the reaction leading to the compound or its salt, the compound of the formula (5) or its salt is more efficiently produced by maintaining the heating temperature, particularly the reflux temperature while removing by-products in the reaction step as necessary. be able to.
- the above two conditions can be satisfied at the same time, which can be suitably used as an industrial production method.
- the azeotropic water and high-boiling point solvent condensate are separated into two layers in the apparatus, and the high-boiling point solvent used in the production method of the present invention is separated into the upper layer.
- the resulting low-boiling substances are distributed to the lower layer (aqueous layer; eg hydrochloric acid). Therefore, by extracting only the lower layer little by little, low-boiling substances are removed from the reaction system, the necessary high reflux temperature is maintained and reaction delay is avoided, and only the upper-boiling solvent in the upper layer is circulated to the reaction tank. And the rise of the interface due to foaming can be continuously suppressed.
- the high-boiling solvent and water (including acid) are removed by extracting the condensate out of the reaction system and separating it without circulating the high-boiling solvent to the reaction vessel. Each can be recovered.
- the collected product can be reused as it is or after appropriate processing.
- the salt of the compound of the formula (5) obtained from the compound of the formula (4) or a salt thereof using a production method leading to the compound of the formula (5) or a salt thereof is It was found to be a dihydrochloride dihydrate of a compound of formula (5), which has been conventionally known!
- the dihydrochloride dihydrate of the compound of the formula (5) of the present invention has better filterability than other known monohydrochlorides of the compound of the formula (5), and the crystals can be taken out by a centrifuge or the like. It will be easy.
- the dihydrochloride dihydrate of the compound of formula (5) has good filterability, it can be obtained as a low-liquid-content, low-humidity wet substance, so that impurities can be easily removed to the filtrate side. Since it can be obtained with a high degree of purity and can be easily dried, it can be mass-produced more efficiently and is a novel substance that is more suitable for storage as an intermediate of the target compound.
- a compound of formula (4) or a salt thereof is mixed with hydrochloric acid and acetic acid.
- hydrochloric acid preferably 8 to 9 parts by volume
- acetic acid preferably 2.5 parts per 1 part by weight of the compound of formula (4) or a salt thereof.
- the total amount of hydrochloric acid and acetic acid should be about 10-12 volume parts.
- the concentration of hydrochloric acid used at this time is usually 12% to 36%, preferably 18 to 22%.
- the reaction is usually performed by heating to 100 ° C. or higher, preferably to the reflux temperature. If the reaction is carried out using the above specific conditions, the desired compound of the formula (5) can be obtained in a short reaction without substantially reducing the yield.
- Another object of the present invention is to prepare a compound of the formula (4) or a salt thereof in a step of producing a compound of the formula (4) or a salt thereof from the compound of the formula (4) or a salt thereof by mixing hydrochloric acid and acetic acid.
- the present invention provides an efficient production method suitable for industrial mass production when heated in liquid to lead to a compound of formula (5).
- the compound of the formula (4) or a salt thereof is heated to be derivatized into the compound of the formula (5) or a salt thereof, and then the compound of the formula (5) or a salt thereof is converted to the 4 Reaction with oral benzoyl chloride provides the desired carbostyril compound of formula (1).
- This reaction can be easily performed by a conventional amide bond formation reaction.
- the reaction liquid is cooled, and if necessary, the reaction liquid is neutralized, and the precipitated crystals are collected by filtration to obtain a carbostyril compound. (1) or its salt can be easily separated and collected.
- the method of the present invention can produce the carboschiri louis compound of formula (1) safely and in large quantities, and is excellent as a method for producing an industrial carbos chilly compound (1).
- the above reaction is usually performed using a conventional base.
- the base include alkali metal hydrogen carbonate (for example, lithium hydrogen carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate, etc.), alkali metal hydroxide (for example, lithium hydroxide, sodium hydroxide, potassium hydroxide hydroxide, Cesium hydroxide, etc.), alkali metal carbonates (eg, lithium carbonate, sodium carbonate, carbonated lithium, cesium carbonate, etc.), alkali metal lower alkoxides (eg, sodium methoxide, sodium ethoxide, potassium tert-butoxide, sodium) tert-butoxide, sodium t ert pentoxide, etc.), alkali metal hydrides (eg, sodium hydride, hydrogenated) Potassium, etc.), alkali metal acetates (eg, sodium acetate, potassium acetate, etc.), trialkylamines [eg, trimethylamine, triethylamine, Nethyldiisoprop
- the ratio of the compound of the formula (5) or a salt thereof and the 4-clobenbenzoyl chloride of the formula (6) is at least equimolar, preferably equimolar to the latter with respect to the former. 2 times mole.
- the base should be used in an amount of at least equimolar with respect to the 4-chlorobenzoic acid lid of formula (6).
- a conventional solvent can be used, and examples thereof include water, methanol, ethanol, propanol, butanol, acetone, acetonitrile, and ethyl acetate, one kind alone or a mixture of two or more kinds. It can also be used.
- the above reaction is usually carried out at about ⁇ 10 to: about L00 ° C., preferably about 0 to 36 ° C., and is usually completed in about 5 minutes to 15 hours to obtain the desired carboschirily compound of formula (1). Obtainable.
- the raw material compounds (2) to (5) in Reaction Scheme 1 may be an appropriate salt or an appropriate reactive derivative.
- the carbostyril compound or salt thereof represented by the formula (1) of the present invention includes stereoisomers, optical isomers and solvates (hydrates, ethanolates, etc.).
- the carbostyril compound represented by the formula (1) of the present invention can be easily converted into an acid addition salt by the action of a pharmaceutically acceptable acid, and the present invention includes this acid addition salt.
- the acid include inorganic acids such as hydrochloric acid, sulfuric acid, phosphoric acid, hydrobromic acid, hydroiodic acid, and nitric acid, acetic acid, oxalic acid, succinic acid, maleic acid, fumaric acid, malic acid, and tartaric acid.
- Examples include acids, citrate, malonic acid, methanesulfonic acid, benzoic acid, trifluoroacetic acid, benzenesulfonic acid, formic acid, toluenesulfonic acid and other organic acids, or amino acids (eg, alginine, aspartic acid, glutamic acid, etc.) Can do.
- the carbostyril compound represented by the formula (1) of the present invention is a pharmaceutically acceptable base.
- a salt can be easily formed by allowing the chemical compound to act.
- such salts include metal salts such as alkali metal salts (for example, sodium salts and potassium salts) and alkaline earth metal salts (for example, calcium salts and magnesium salts); ammonium salts; organic base salts (For example, trimethylamine salt, triethylamine salt, pyridine salt, picolin salt, dicyclohexylamine salt, N, N, -dibenzylethylenediamine salt, etc.).
- the basic compound include sodium hydroxide, potassium hydroxide, calcium hydroxide, sodium carbonate, potassium hydrogen carbonate and the like.
- the carbostyril compound represented by the formula (1) of the present invention is more efficiently absorbed into the living body by reducing the particle diameter with a normal pulverizer (for example, an atomizer). It can be carried out.
- a normal pulverizer for example, an atomizer
- the particle size can be easily reduced by a known method well known to those skilled in the art.
- the method can be refined by a ceramic mill under suitable conditions such as the mill rotation ratio or the feed ratio of the carboschilli compound (1). It can also be refined by passing through an air jet mill with an appropriate supply air pressure while rotating at an appropriate supply ratio or rotation ratio of the carboschilli compound represented by the formula (1) of the present invention. Is possible.
- the danger of bumping can be avoided by using a high-boiling solvent, so that a desired carbostyril compound or salt thereof of the formula (1) can be produced safely,
- the volumetric efficiency of the reactor can be greatly increased, which is extremely effective for mass synthesis.
- the high-boiling solvent used is easily recovered by distilling off during the reaction, or by separating the liquid after distilling off the reaction.
- the acid (hydrochloric acid) filtrate after solid-liquid separation can be reused without discarding the majority of the fractions except the initial fraction by performing a simple distillation operation. Since it can be recovered as (hydrochloric acid), adverse effects on the environment can be reduced.
- the post-treatment after completion of the reaction can obtain the compound of formula (5) or a salt thereof in a high yield by a simple operation of crystal filtration after cooling. It is effective for the large-scale synthesis of the carboschiril compound of formula (1) or a salt thereof.
- the dihydrochloride dihydrate of the compound of the formula (5) of the present invention is crystallized by a centrifuge or the like, which has better filterability than other known monohydrochlorides of the compound of the formula (5). It becomes easy to take out.
- the dihydrochloride dihydrate of the compound of formula (5) has good filterability, it can be obtained as a low-liquid-content, low-humidity wet substance, so that impurities can be easily removed to the filtrate side. Since it can be obtained with a high degree of purity and can be easily dried, it can be mass-produced more efficiently and is a novel substance that is more suitable for storage as an intermediate of the target compound.
- the compound of the formula (4) or a salt thereof As another production method leading from the compound of the formula (4) or a salt thereof to the compound of the formula (5) or a salt thereof, the compound of the formula (4) or By heating the salt in a mixture of hydrochloric acid and acetic acid at a certain ratio, the increase in the interface due to foaming can be suppressed to an acceptable level in industrial mass production without adding a high-boiling solvent. In addition, the reaction can be completed in a relatively short time.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/596,004 US7718806B2 (en) | 2005-04-28 | 2006-04-07 | Process for production of carbostyril compound |
CN2006800004646A CN1989108B (en) | 2005-04-28 | 2006-04-07 | Method for producing carbostyryl compound |
IL179235A IL179235A (en) | 2005-04-28 | 2006-11-13 | Process for production of carbostyril compound that is useful as a medicament for treating gastric ulcer and the like |
KR1020067024388A KR101265877B1 (en) | 2005-04-28 | 2006-11-21 | Process for preparing carbostyril compounds |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005132486 | 2005-04-28 | ||
JP2005-132486 | 2005-04-28 | ||
JP2006087654A JP3892894B2 (en) | 2005-04-28 | 2006-03-28 | Method for producing carbostyril compound |
JP2006-087654 | 2006-03-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006117977A1 true WO2006117977A1 (en) | 2006-11-09 |
Family
ID=37307781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2006/307461 WO2006117977A1 (en) | 2005-04-28 | 2006-04-07 | Process for production of carbostyril compound |
Country Status (6)
Country | Link |
---|---|
US (1) | US7718806B2 (en) |
JP (1) | JP3892894B2 (en) |
KR (1) | KR101265877B1 (en) |
CN (1) | CN1989108B (en) |
IL (1) | IL179235A (en) |
WO (1) | WO2006117977A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010043053A (en) * | 2008-08-11 | 2010-02-25 | Dongwoo Syntech Co Ltd | Process for producing high purity rebamipide |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6642245B1 (en) * | 1990-02-01 | 2003-11-04 | Emory University | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
US5728575A (en) * | 1990-02-01 | 1998-03-17 | Emory University | Method of resolution of 1,3-oxathiolane nucleoside enantiomers |
CN113248429A (en) * | 2021-06-01 | 2021-08-13 | 千辉药业(安徽)有限责任公司 | Preparation method of rebamipide bulk drug |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6019767A (en) * | 1983-07-11 | 1985-01-31 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
JPH037264A (en) * | 1988-04-22 | 1991-01-14 | Inst Natl Sante & Rech Med <Inserm> | Hystamine derivative, production thereof and medicine containing said derivative |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4578381A (en) * | 1982-07-05 | 1986-03-25 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
JP2820739B2 (en) | 1989-10-28 | 1998-11-05 | 大塚製薬株式会社 | Method for producing carbostyril derivatives |
JP3145468B2 (en) | 1992-02-27 | 2001-03-12 | マニー株式会社 | Lower die mounting structure in caulking device |
KR100669823B1 (en) | 2001-02-20 | 2007-01-17 | 경동제약 주식회사 | Process for Preparing 2-4-Chlorobenzoylamino-3-[21?- quinolinon-4-yl]propionic acid and intermediate thereof |
KR100766578B1 (en) | 2001-12-18 | 2007-10-11 | 동화약품공업주식회사 | A process for preparing rebamipide |
KR100520184B1 (en) | 2002-10-11 | 2005-10-10 | 한미약품 주식회사 | Improved method for the preparation of rebamipide |
KR200350412Y1 (en) | 2004-02-26 | 2004-05-12 | (주)티에스이 | Clamping block of coaxial cable |
-
2006
- 2006-03-28 JP JP2006087654A patent/JP3892894B2/en active Active
- 2006-04-07 US US11/596,004 patent/US7718806B2/en not_active Expired - Fee Related
- 2006-04-07 CN CN2006800004646A patent/CN1989108B/en not_active Expired - Fee Related
- 2006-04-07 WO PCT/JP2006/307461 patent/WO2006117977A1/en active Application Filing
- 2006-11-13 IL IL179235A patent/IL179235A/en not_active IP Right Cessation
- 2006-11-21 KR KR1020067024388A patent/KR101265877B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6019767A (en) * | 1983-07-11 | 1985-01-31 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
JPH037264A (en) * | 1988-04-22 | 1991-01-14 | Inst Natl Sante & Rech Med <Inserm> | Hystamine derivative, production thereof and medicine containing said derivative |
Non-Patent Citations (2)
Title |
---|
UCHIDA M. ET AL.: "Studies on 2(1H)-quinolinone derivatives as gastric antiulcer active agents. 2-(4-Chlorobenzoylamino)-3-[2(1H)-quinolinon-4-yl]propionic acid and related compounds", CHEMICAL & PHARMACEUTICAL BULLETIN, vol. 33, no. 9, 1985, pages 3775 - 3786, XP001208323 * |
YE Y. ET AL.: "Synthesis and physiological activity of 1,2-dihydro-2-oxoquinoline derivatives", BEIJING DAXUE XUEBAO, ZIRAN KEXUEBAN, vol. 26, no. 2, 1990, pages 207 - 213, XP008072198 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010043053A (en) * | 2008-08-11 | 2010-02-25 | Dongwoo Syntech Co Ltd | Process for producing high purity rebamipide |
Also Published As
Publication number | Publication date |
---|---|
US20070299262A1 (en) | 2007-12-27 |
IL179235A0 (en) | 2007-03-08 |
KR101265877B1 (en) | 2013-05-20 |
US7718806B2 (en) | 2010-05-18 |
CN1989108A (en) | 2007-06-27 |
IL179235A (en) | 2012-02-29 |
JP3892894B2 (en) | 2007-03-14 |
CN1989108B (en) | 2011-02-23 |
KR20080019151A (en) | 2008-03-03 |
JP2006328045A (en) | 2006-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
USRE49860E1 (en) | Process for preparing (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide and purification thereof for use as pharmaceutical active ingredient | |
JP6899413B2 (en) | Methods for Synthesizing Thyroid Hormone Analogs and Their Polymorphs | |
CN103080100B (en) | The manufacture method of 1-triazole-2-butanol derivs thing | |
CN108912109A (en) | A kind of high-purity, small particle and azilsartan crude drug of low solvent residue and preparation method thereof | |
WO2006117977A1 (en) | Process for production of carbostyril compound | |
KR20180101610A (en) | An improved preparation of osmitaminib (AZD9291) or a salt thereof, and &quot; AZD9291 aniline &quot; or a salt thereof | |
JP6225998B2 (en) | Method for producing indoline compound | |
CN105517992B (en) | Novel crystalline aralkylamine compound and its manufacturing method | |
CN108586450B (en) | Recrystallization purification method of choline M receptor anticaking agent | |
KR101865868B1 (en) | Process for large scale production of 1-isopropyl-3-[5-[1-(3-methoxypropyl) piperidin-4-yl]-[1,3,4]oxadiazol-2-yl]-1h-indazole oxalate | |
EP2934502A1 (en) | Process for prepararing n-(2-(7-methoxy-1-naphthalenyl)ethyl) acetamide and solid forms thereof | |
JP7536950B2 (en) | Method for producing prolinamide compound | |
CA2703465A1 (en) | Synthesis and crystalline forms of cb-1 antagonist/inverse agonist | |
CN114466845A (en) | Process for the preparation of 5- (4- ((2S,5S) -5- (4-chlorobenzyl) -2-methylmorpholino) piperidin-1-yl) -1H-1,2, 4-triazol-3-amine | |
JP5448588B2 (en) | Method for purifying L-carnosine | |
JPH1180128A (en) | Purification and stabilization of 5,6-diamino-1,3-di-(2-propenyl)uracil | |
JPH06345735A (en) | Production of n-substituted-3-piperidinol | |
WO2008152514A2 (en) | Process for the preparation of alfuzosin and salts thereof | |
TW201634443A (en) | Method for producing 2-aminoethylmethacrylate hydrochloride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 11596004 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 179235 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 6784/DELNP/2006 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067024388 Country of ref document: KR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 200680000464.6 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06731408 Country of ref document: EP Kind code of ref document: A1 |